Reply to: Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C

被引：0
|
作者：
Sakin, Yusuf Serdar [1 ]
Polat, Zulfikar [1 ]
Demirci, Hakan [1 ]
Kekilli, Murat [2 ]
Uygun, Ahmet [1 ]
Bagci, Sait [1 ]
机构：
[1] Gulhane Mil Med Acad, Dept Gastroenterol, Ankara, Turkey
[2] Hitit Univ, Corum, Turkey
来源：
HEPATOLOGY RESEARCH | 2014年 / 44卷 / 09期
关键词：
D O I：
10.1111/hepr.12278
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1037 / 1037
页数：1
相关论文
共 50 条
  • [21] Dynamics of liver stiffness during peginterferon alpha-ribavirin treatment in patients with chronic hepatitis C
    Hezode, Christophe
    Castera, Laurent
    Rosa, Isabelle
    Roulot, Dominique
    Leroy, Vincent
    Bouvier-Alias, Magali
    Dhalluin-Venier, Valerie
    Roudot-Thoraval, Francoise
    Mallat, Ariane
    Pawlotsky, Jean-Michel
    GASTROENTEROLOGY, 2008, 134 (04) : A774 - A774
  • [22] Thrombocytopenia and the risk of bleeding during treatment with peginterferon alfa and ribavirin for chronic hepatitis C
    Roomer, Robert
    Hansen, Bettina E.
    Janssen, Harry L. A.
    de Knegt, Robert J.
    JOURNAL OF HEPATOLOGY, 2010, 53 (03) : 455 - 459
  • [23] INFECTIONS DURING TREATMENT WITH PEGINTERFERON ALFA AND RIBAVIRIN FOR CHRONIC HEPATITIS C ARE NOT ASSOCIATED WITH NEUTROPENIA
    Roomer, Robert
    Hansen, Bettina E.
    Janssen, Harry L.
    de Knegt, Robert J.
    HEPATOLOGY, 2009, 50 (04) : 317A - 318A
  • [24] Risk Factors for Infection During Treatment with Peginterferon alfa and Ribavirin for Chronic Hepatitis C
    Roomer, Robert
    Hansen, Bettina E.
    Janssen, Harry L. A.
    de Knegt, Robert J.
    HEPATOLOGY, 2010, 52 (04) : 1225 - 1231
  • [25] Changes in Mood States and Biomarkers During Peginterferon and Ribavirin Treatment of Chronic Hepatitis C
    Fontana, Robert J.
    Kronfol, Ziad
    Lindsay, Karen L.
    Bieliauskas, Linas A.
    Padmanabhan, Latha
    Back-Madruga, Carla
    Lok, Anna S. F.
    Stoddard, Anne M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (11): : 2766 - 2775
  • [26] COST-UTILITY ANALYSIS OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALPHA AND RIBAVIRIN IN PREVIOUSLY TREATED PATIENTS WITH CHRONIC HEPATITIS C
    Lukac, M.
    Bielik, J.
    Holoman, J.
    Tomek, D.
    Suvadova, A.
    Foltanova, T.
    Foltan, V
    VALUE IN HEALTH, 2012, 15 (07) : A330 - A330
  • [27] Similar Treatment Response to Peginterferon and Ribavirin in Asian and Caucasian Patients With Chronic Hepatitis C
    Vutien, Philip
    Nguyen, Nghia H.
    Trinh, Huy N.
    Li, Jiayi
    Garcia, Ruel T.
    Garcia, Gabriel
    Nguyen, Khanh K.
    Nguyen, Huy A.
    Levitt, Brian S.
    Keeffe, Emmet B.
    Nguyen, Mindie H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (05): : 1110 - 1115
  • [28] Retreatment with peginterferon and ribavirin in chronic hepatitis C
    Yong Min Jo
    Sung Wook Lee
    Sang Young Han
    Yang Hyun Baek
    Soo Young Kim
    Woo Jae Kim
    Ji Hye Ahn
    Ji Young Lee
    World Journal of Gastroenterology, 2015, (06) : 1994 - 1999
  • [29] Retreatment with peginterferon and ribavirin in chronic hepatitis C
    Jo, Yong Min
    Lee, Sung Wook
    Han, Sang Young
    Baek, Yang Hyun
    Kim, Soo Young
    Kim, Woo Jae
    Ahn, Ji Hye
    Lee, Ji Young
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (06) : 1994 - 1999
  • [30] Suitable treatment period in patients with virological response during combination therapy of peginterferon and ribavirin for chronic hepatitis C
    Arase, Yasuji
    Suzuki, Fumitaka
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Kawamura, Yusuke
    Kobayashi, Masahiro
    Akuta, Norio
    Hosaka, Tetsuya
    Yatsuji, Hiromi
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    INTERNAL MEDICINE, 2008, 47 (14) : 1301 - 1307
12345